"Autologous cultured cell technology has created a new
dimension in tissue engineering and regenerative medicine, which will diminish
the burden of risks associated with auto and allografts", says Dr. Satyen
Sanghavi, Chief Scientific Officer, Regrow®.
"Regenerating patient's own bones would be like giving her
an original jaw, thus in future she can fix permanent prosthesis (denture)",
said Dr. Vaidya.
Ameloblastoma is a benign tumor of odontogenic epithelium
commonly appears in the mandible. While these tumors progress slowly, the
resulting lesions can cause severe abnormalities of the face and jaw.
Additionally, because abnormal cell growth easily infiltrates and destroys
surrounding bony tissues, wide surgical excision is required to treat this
disorder. Even then, the defect remains permanent and there is no treatment
available.
Post the biopsy, Dr. Vaidya sent the sample of the cell from
patient's body to "Cell Processing
Center" of Regrow®, where it was
isolated, differentiated and osteoblasts were cultured for five weeks. Finally,
this morning, on 7th September 2010,
the cultured osteoblasts cells which have the regenerative capability were
implanted on the defect site of the patient. Thus, now this implant will start
to form new bone growth at the defect area.
"We were very happy that the implant was done through
autologous reconstruction using Meenakshi's own body tissue, thus, making the
treatment absolutely natural and safe", said the patient's husband, Mr.
Kudekar.
Source: Medindia
